The store will not work correctly when cookies are disabled.
US8889672, 317-120-001
ID: ALA3702544
PubChem CID: 71009781
Max Phase: Preclinical
Molecular Formula: C20H18N2O4S
Molecular Weight: 382.44
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cccc(COC(=O)c2c(-c3ccc(C(N)=O)cc3)csc2N)c1
Standard InChI: InChI=1S/C20H18N2O4S/c1-25-15-4-2-3-12(9-15)10-26-20(24)17-16(11-27-19(17)22)13-5-7-14(8-6-13)18(21)23/h2-9,11H,10,22H2,1H3,(H2,21,23)
Standard InChI Key: PZLGAGDROBQFAL-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
2.5956 -2.7031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5972 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5951 -3.0039 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9336 -3.1588 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8912 -5.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1017 -6.1219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2420 -5.7483 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.6332 -7.5468 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-3.1332 -7.5416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6746 -6.1134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2518 -5.6362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8403 -4.1992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6153 -3.8367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6570 -4.9160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2431 -6.3578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2124 -6.7203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1141 -4.5563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9462 -5.4209 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4471 -3.4034 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 2 0
10 12 1 0
12 13 2 0
13 14 1 0
13 15 1 0
15 16 1 0
16 17 2 0
17 12 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
21 24 1 0
24 25 2 0
24 26 1 0
7 27 2 0
27 3 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 382.44 | Molecular Weight (Monoisotopic): 382.0987 | AlogP: 3.46 | #Rotatable Bonds: 6 |
Polar Surface Area: 104.64 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.81 | CX LogD: 3.81 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.64 | Np Likeness Score: -0.95 |
References
1. (2014) Compounds, formulations, and methods of protein kinase C inhibition, |